{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T20:04:55Z","timestamp":1787169895274,"version":"build-2736575974"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>\n                      Elevated circulating anti-M\u00fcllerian hormone (AMH) in women with the polycystic ovarian syndrome (PCOS) has been found to have a detrimental effect on endometrial function. This may adversely affect the outcome of\n                      <jats:italic toggle=\"yes\">in vitro<\/jats:italic>\n                      fertilisation (IVF) in PCOS women.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims:<\/jats:title>\n                    <jats:p>To investigate the impact of high serum AMH concentrations on endometrial thickness (ET) and the outcome of IVF in women with PCOS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Settings and Design:<\/jats:title>\n                    <jats:p>This retrospective cohort study included all PCOS women who underwent fresh IVF\\intracytoplasmic sperm injection cycles between January 2016 and December 2021 in one major IVF centre.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>PCOS diagnosis was based on Rotterdam criteria, and participants were identified from centre database. All women received antagonist protocol. Primary outcomes were trigger-day ET and live birth rate (LBR). Circulating AMH was correlated with ET and ovarian response.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Statistical Analysis Used:<\/jats:title>\n                    <jats:p>AMH levels were compared between women with and without live birth. ET and LBRs were compared between women with AMH &lt;7.0 ng\/ml versus those with AMH \u22657.0 ng\/ml.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The study included 102 PCOS women, of which six were excluded due to poor response (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 4), hyperresponse (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 1) or fertilisation failure (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 1). Of the remaining 96 women, 42 (43.8%) achieved a live birth. There was no statistically significant (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &gt; 0.05) correlation between AMH and ET. Mean \u00b1 standard deviation AMH concentration was not significantly (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &gt; 0.05) different between women with live birth (6.5 \u00b1 3.4 ng\/ml) and those without (6.5 \u00b1 2.4 ng\/ml). High AMH positively correlated with the number of oocytes retrieved, metaphase II oocytes and embryos (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.003, 0.006 and 0.006, respectively). There was no statistically significant (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &gt; 0.05) difference in ET or LBR between women with AMH &lt;7.0 ng\/ml (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 72; ET, 10.7 \u00b1 1.8 mm; LBR, 45.8% [33\/72] versus those with AMH \u22657.0 ng\/ml (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 24; ET, 10.8 \u00b1 1.7 mm; LBR, 37.5% [9\/24]).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>High circulating AMH in PCOS women does not seem to negatively affect ET or LBRs during assisted reproductive technology.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jhrs.jhrs_112_22","type":"journal-article","created":{"date-parts":[[2023,4,15]],"date-time":"2023-04-15T05:57:35Z","timestamp":1681538255000},"page":"370-376","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["The Impact of High Circulating Anti-M\u00fcllerian Hormone on Endometrial Thickness and Outcome of Assisted Reproductive Technology in Women with Polycystic Ovarian Syndrome"],"prefix":"10.4103","volume":"15","author":[{"given":"Ahmed Aboelfadle","family":"Mohamed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarek K.","family":"Al-Hussaini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reda S.","family":"Hussein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karim S.","family":"Abdallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saad A.","family":"Amer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-8-20240905","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/humupd\/dmp036","article-title":"Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART)","volume":"16","author":"La Marca","year":"2010","journal-title":"Hum Reprod Update"},{"key":"R2-8-20240905","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/humupd\/dmu003","article-title":"The predictive accuracy of anti-M\u00fcllerian hormone for live birth after assisted conception: A systematic review and meta-analysis of the literature","volume":"20","author":"Iliodromiti","year":"2014","journal-title":"Hum Reprod Update"},{"key":"R3-8-20240905","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/s00404-020-05498-2","article-title":"AMH-based ovarian stimulation versus conventional ovarian stimulation for IVF\/ICSI: A systematic review and meta-analysis","volume":"301","author":"Cui","year":"2020","journal-title":"Arch Gynecol Obstet"},{"key":"R4-8-20240905","doi-asserted-by":"crossref","first-page":"4170","DOI":"10.1210\/jc.2013-2193","article-title":"The predictive value of circulating anti-M\u00fcllerian hormone in women with polycystic ovarian syndrome receiving clomiphene citrate: A prospective observational study","volume":"98","author":"Mahran","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"R5-8-20240905","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1093\/humrep\/dep271","article-title":"The value of measuring anti-Mullerian hormone in women with anovulatory polycystic ovary syndrome undergoing laparoscopic ovarian diathermy","volume":"24","author":"Amer","year":"2009","journal-title":"Hum Reprod"},{"key":"R6-8-20240905","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/1477-7827-11-115","article-title":"The influence of circulating anti-M\u00fcllerian hormone on ovarian responsiveness to ovulation induction with gonadotrophins in women with polycystic ovarian syndrome: A pilot study","volume":"11","author":"Amer","year":"2013","journal-title":"Reprod Biol Endocrinol"},{"key":"R7-8-20240905","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1093\/humupd\/dmaa051","article-title":"Endometrial function in women with polycystic ovary syndrome: A comprehensive review","volume":"27","author":"Palomba","year":"2021","journal-title":"Hum Reprod Update"},{"key":"R8-8-20240905","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1093\/humupd\/dmt062","article-title":"The physiology and clinical utility of anti-Mullerian hormone in women","volume":"20","author":"Dewailly","year":"2014","journal-title":"Hum Reprod Update"},{"key":"R9-8-20240905","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.rbmo.2020.01.032","article-title":"Endometrial expression of anti-M\u00fcllerian hormone and its type II receptor in women with polycystic ovary syndrome","volume":"41","author":"Paulson","year":"2020","journal-title":"Reprod Biomed Online"},{"key":"R10-8-20240905","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.fertnstert.2008.01.028","article-title":"Evidence for a M\u00fcllerian-inhibiting substance autocrine\/paracrine system in adult human endometrium","volume":"91","author":"Wang","year":"2009","journal-title":"Fertil Steril"},{"key":"R11-8-20240905","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1756-9966-33-46","article-title":"Anti-mullerian hormone is expressed by endometriosis tissues and induces cell cycle arrest and apoptosis in endometriosis cells","volume":"33","author":"Signorile","year":"2014","journal-title":"J Exp Clin Cancer Res"},{"key":"R12-8-20240905","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.fertnstert.2011.08.015","article-title":"Anti-M\u00fcllerian hormone reduces follicle sensitivity to follicle-stimulating hormone in human granulosa cells","volume":"96","author":"Pellatt","year":"2011","journal-title":"Fertil Steril"},{"key":"R13-8-20240905","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/humupd\/dmh010","article-title":"The follicular excess in polycystic ovaries, due to intra-ovarian hyperandrogenism, may be the main culprit for the follicular arrest","volume":"10","author":"Jonard","year":"2004","journal-title":"Hum Reprod Update"},{"key":"R14-8-20240905","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.fertnstert.2007.03.066","article-title":"M\u00fcllerian-inhibiting substance inhibits cytochrome P450 aromatase activity in human granulosa lutein cell culture","volume":"89","author":"Grossman","year":"2008","journal-title":"Fertil Steril"},{"key":"R15-8-20240905","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1210\/jcem.84.8.5929","article-title":"Androgen and follicle-stimulating hormone interactions in primate ovarian follicle development","volume":"84","author":"Weil","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"R16-8-20240905","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s10815-012-9726-x","article-title":"Correlation of serum anti-M\u00fcllerian hormone concentrations on day 3 of the in vitro fertilization stimulation cycle with assisted reproduction outcome in polycystic ovary syndrome patients","volume":"29","author":"Xi","year":"2012","journal-title":"J Assist Reprod Genet"},{"key":"R17-8-20240905","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12958-020-00581-4","article-title":"High serum antimullerian hormone levels are associated with lower live birth rates in women with polycystic ovarian syndrome undergoing assisted reproductive technology","volume":"18","author":"Tal","year":"2020","journal-title":"Reprod Biol Endocrinol"},{"key":"R18-8-20240905","doi-asserted-by":"crossref","first-page":"673284","DOI":"10.3389\/fendo.2021.673284","article-title":"High serum anti-M\u00fcllerian hormone concentrations are associated with poor pregnancy outcome in fresh IVF\/ICSI cycle but not cumulative live birth rate in PCOS patients","volume":"12","author":"Guo","year":"2021","journal-title":"Front Endocrinol (Lausanne"},{"key":"R19-8-20240905","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.fertnstert.2014.09.041","article-title":"Antim\u00fcllerian hormone as predictor of implantation and clinical pregnancy after assisted conception: A systematic review and meta-analysis","volume":"103","author":"Tal","year":"2015","journal-title":"Fertil Steril"},{"key":"R20-8-20240905","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s12884-022-04518-0","article-title":"Association of antim\u00fcllerian hormone with polycystic ovarian syndrome phenotypes and pregnancy outcomes of in vitro fertilization cycles with fresh embryo transfer","volume":"22","author":"Liu","year":"2022","journal-title":"BMC Pregnancy Childbirth"},{"key":"R21-8-20240905","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1210\/jc.2012-3676","article-title":"Antim\u00fcllerian hormone levels are strongly associated with live-birth rates after assisted reproduction","volume":"98","author":"Brodin","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"R22-8-20240905","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1016\/j.fertnstert.2009.12.002","article-title":"Serum antim\u00fcllerian hormone concentrations on day 3 of the in vitro fertilization stimulation cycle are predictive of the fertilization, implantation, and pregnancy in polycystic ovary syndrome patients undergoing assisted reproduction","volume":"94","author":"Kaya","year":"2010","journal-title":"Fertil Steril"},{"key":"R24-8-20240905","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.rbmo.2018.05.003","article-title":"Cumulative live birth rates after IVF in patients with polycystic ovaries: Phenotype matters","volume":"37","author":"De Vos","year":"2018","journal-title":"Reprod Biomed Online"},{"key":"R25-8-20240905","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.rbmo.2016.01.010","article-title":"Assisted reproductive outcomes in women with different polycystic ovary syndrome phenotypes: The predictive value of anti-M\u00fcllerian hormone","volume":"32","author":"Ramezanali","year":"2016","journal-title":"Reprod Biomed Online"},{"key":"R26-8-20240905","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1080\/09513590.2019.1650343","article-title":"Association between prolactin receptor expression and proliferation in the endometrium of obese women with polycystic ovary syndrome","volume":"36","author":"Paulson","year":"2020","journal-title":"Gynecol Endocrinol"},{"key":"R27-8-20240905","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.celrep.2016.06.043","article-title":"Anti-M\u00fcllerian hormone signaling regulates epithelial plasticity and chemoresistance in lung cancer","volume":"16","author":"Beck","year":"2016","journal-title":"Cell Rep"},{"key":"R28-8-20240905","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.mce.2003.09.006","article-title":"Genetic studies of the AMH\/MIS signaling pathway for M\u00fcllerian duct regression","volume":"211","author":"Jamin","year":"2003","journal-title":"Mol Cell Endocrinol"},{"key":"R29-8-20240905","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.fertnstert.2007.11.063","article-title":"Infertile women with isolated polycystic ovaries are deficient in endometrial expression of osteopontin but not alphavbeta3 integrin during the implantation window","volume":"91","author":"DuQuesnay","year":"2009","journal-title":"Fertil Steril"}],"container-title":["Journal of Human Reproductive Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jhrs.jhrs_112_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:14:36Z","timestamp":1787166876000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jhrs.jhrs_112_22"}},"subtitle":["A Cohort Study"],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/jhrs.jhrs_112_22","relation":{},"ISSN":["0974-1208"],"issn-type":[{"value":"0974-1208","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]}}}